Brief: Bellerophon Therapeutics Says On June 24, Board Approved Reduction-In-Force Of Substantially All Of Co’S Employees,Including Executive Officers
29/06/2023 21:32
June 29 (Reuters) - Bellerophon Therapeutics Inc
BLPH.O :
* BELLEROPHON THERAPEUTICS INC- ON JUNE 24, BOARD APPROVED
REDUCTION-IN-FORCE OF SUBSTANTIALLY ALL OF CO’S
EMPLOYEES,INCLUDING EXECUTIVE OFFICERS
* BELLEROPHON THERAPEUTICS INC- CO INTENDS TO EXPLORE A
RANGE OF
STRATEGIC ALTERNATIVES TO MAXIMIZE STOCKHOLDER VALUE
Source text for Eikon: ID:
Further company coverage: BLPH.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen